Anavex Life Sciences Corp.

NASDAQ:AVXL

Biotechnology

Healthcare
$0.72 -1.67%

-$0.04 today

Market cap
$66.69M
Beta
1.12
P/E (TTM)
-5.9
EPS (TTM)
-$0.45
52W Low $2.41High $13.99

Volume 1.06M

Average 1.39M

AVXL Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Anavex Life Sciences Corp.NASDAQ: AVXL

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Dec 2025

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 89.03M shares rose 5.0% year over year, ahead of the +2.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 3.7% from the prior quarter. Over 3 fiscal years it compounded at +3.5% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +5.0% holds above the trailing-twelve-month pace of +2.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
89.03M+3.7% QoQ
Last fiscal yearSep 2025
85.29M+2.2% YoY
LTMDec 2025
86.34M+2.9% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+5.0%——
1 year+2.2%——
3-year CAGR+3.5%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
85.29M USD
Year-over-year change
+2.2%
4-year CAGR
+5.1%

Weighted Avg Shares (Diluted) vs competitors

How AVXL compares with its peers on the latest reported figures

  • AVXL's LTM Dec 2025 weighted avg shares (diluted) of 86.34M shares is the 4th highest of the 10 companies compared; the peer median is 80.99M shares.
  • Its year-over-year change of +2.9% is the 8th highest of 10, against a peer median of +13.7%.
  • Over three fiscal years its annual growth of +3.5% compares with a peer median of +14.6%.
AVXL Competitors Peer median
Weighted Avg Shares (Diluted) for AVXL and competitors
Company Period LTM YoY 3-year CAGR
ERASErasca, Inc.LTM Sep 2026310.86M +9.7%+32.5%
CTMXCytomX Therapeutics, Inc.LTM Mar 2026160.38M +90.2%+28.0%
ABSIAbsci CorporationLTM Mar 2026143.73M +23.4%+14.6%
AVXLAnavex Life Sciences Corp.LTM Dec 202586.34M +2.9%+3.5%
VALNValneva SELTM Mar 202683.89M +18.5%+13.4%
MGTXMeiraGTx Holdings plcLTM Mar 202680.99M +13.7%+21.2%
ARVNArvinas, Inc.LTM Mar 202668.7M -4.8%+6.9%
MLTXMoonLake ImmunotherapeuticsLTM Mar 202665.6M +4.1%+30.0%
RGNXREGENXBIO Inc.LTM Mar 202651.84M +1.8%+6.1%
MBXMBX Biosciences, Inc. Common StockLTM Sep 202644.83M +33.4%+4.6%
Peer median (excluding AVXL) 80.99M+13.7%+14.6%

Competitors are the stored peer set for AVXL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Sep 2021
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development32.98M37.92M43.72M41.84M37.59M
Selling, General & Admin9.02M13.07M12.05M11.04M13.82M
Operating Expenses42M50.99M55.76M52.88M51.41M
Depreciation & Amortization00000
EBITDA(37.64M)(47.62M)(46.54M)(43M)(46.38M)
EBITDA Margin—————
Operating Income(42M)(50.99M)(55.76M)(52.88M)(51.41M)
Operating Margin—————
Interest Income26K947K6.52M7.32M4.68M
Interest Expense00964K00
Other Income / Expenses4.36M3.37M8.26M9.88M5.03M
Income Before Tax(37.64M)(47.62M)(47.51M)(43M)(46.38M)
Pre-Tax Margin—————
Income Tax Expense268K358K000
Net Income(37.91M)(47.98M)(47.51M)(43M)(46.38M)
Net Margin—————
EPS (Basic)(0.54)(0.62)(0.60)(0.52)(0.54)
EPS (Diluted)(0.54)(0.62)(0.60)(0.52)(0.54)
Weighted Avg Shares69.8M76.91M79.79M83.47M85.29M
Weighted Avg Shares (Diluted)69.8M76.91M79.79M83.47M85.29M

Anavex Life Sciences Corp.

NASDAQ:AVXL

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.